SCHEMBL13801583

SCHEMBL13801583

CS(=O)(=O)c1ccc(Nc2ncnc3[nH]c(Nc4c(Cl)cccc4Cl)nc23)cc1F

nearest known ligand 0.50

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 14/20 0.50
GRM4 Q14833 3/20 0.48
AURKA O14965 1/20 0.39
RPS6KB1 P23443 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13801563 0.84 TRPV1 (0.69) TRPV1AURKA
SCHEMBL14289482 0.84 TRPV1 (0.72) TRPV1
SCHEMBL13813956 0.83 TRPV1 (0.48) TRPV1AURKARPS6KB1
SCHEMBL13801581 0.81 TRPV1 (0.59) TRPV1
SCHEMBL13801560 0.77 TRPV1 (0.68) TRPV1
SCHEMBL13801582 0.77 TRPV1 (0.70) TRPV1GRM4
SCHEMBL4162780 0.77 GRM4 (0.43) TRPV1GRM4AURKARPS6KB1
SCHEMBL4215209 0.77 TRPV1 (0.52) TRPV1GRM4
SCHEMBL13801562 0.77 TRPV1 (0.64) TRPV1
SCHEMBL13801558 0.75 TRPV1 (0.68) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156598-A1 Imidazolopyrimidine modulators of TRPV1 JANSSEN PHARMACEUTICA NV (BE) 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156598-A1 Imidazolopyrimidine modulators of TRPV1 TRPV1, TRPV2, TRPV5 TRPV1 1/4885GRM4 759/4885AURKA 2192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.